Search Medical Condition
Please enter condition
Please choose location

Merrick, New York Clinical Trials

A listing of Merrick, New York clinical trials actively recruiting patient volunteers.

RESULTS

Found (370) clinical trials

Efficacy and Safety of Artacent for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers

This study is to document the efficacy of Artacent™ Human Amniotic Membrane (Artacent) in the treatment of diabetic and vascular lower extremity ulcers. The study will add to the currently available literature by also assessing the impact of treatment on quality of life and on heal economic outcomes. Finally the ...

Phase N/A

0.95 miles

Learn More »

Safety and Efficacy of KPI-12 in Subjects With Dry Eye Disease

This is a Phase 3, multi-center, double-masked, randomized, vehicle-controlled, parallel-group study designed to evaluate the safety and efficacy of KPI-121 0.25% ophthalmic suspension versus vehicle in subjects with dry eye disease.

Phase

2.54 miles

Learn More »

Pediatric Residency Training On Tobacco

The American Academy of Pediatrics and other leading health agencies call upon pediatricians to address environmental tobacco smoke (ETS), prevent smoking onset in youths, and encourage cessation of tobacco use by adolescents and their parents. Systematic intervention on tobacco by pediatricians would protect infants and young children from the harmful ...

Phase

3.21 miles

Learn More »

This clinical trial is provided by Antidote. People with certain conditions such as Multiple Sclerosis (MS) and Spinal Cord Injury (SCI) may experience urinary incontinence, or involuntary urine loss, as a result of the bladder muscle not relaxing and contracting too often. Oral medications are available but do not work ...

Phase

3.37 miles

Learn More »

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian Fallopian Tube or Primary Peritoneal Cancer

PRIMARY OBJECTIVES: I. Assess the efficacy of either single agent olaparib or the combination of cediranib (cediranib maleate) and olaparib, as measured by progression free survival (PFS), as compared to standard platinum-based chemotherapy in the setting of recurrent platinum-sensitive ovarian, primary peritoneal or fallopian tube cancer. SECONDARY OBJECTIVES: I. Assess ...

Phase

4.44 miles

Learn More »